» Articles » PMID: 20101686

Terminal 3p Deletions in Two Families--correlation Between Molecular Karyotype and Phenotype

Overview
Specialty Genetics
Date 2010 Jan 27
PMID 20101686
Citations 19
Authors
Affiliations
Soon will be listed here.
Abstract

The 3p deletion syndrome is a rare disorder caused by deletions of different sizes in the 3p25-pter region. It is characterized by growth retardation, developmental delay, mental retardation, dysmorphism, microcephaly, and ptosis. The phenotype of individuals with deletions varies from normal to severe. Most cases occur de novo, but a few familial cases have been reported. We describe two families with terminal 3p deletions and extremely variable clinical features. In family A, the mother and daughter were extremely mildly affected whereas the son had more severe clinical features. In family B, the mother was normal and her son was affected, having some symptoms that had not been described in the 3p deletion syndrome before. The deletions were characterized by genome-wide SNP array analysis and were 9 and 1.1 Mb in size. Sequencing analysis of the CHL1, CNTN4, and CRBN genes did not reveal any masked recessive alleles that might explain the more severe phenotypes in the probands. In family A, the 9 Mb deletion can be considered causal for the 3p deletion syndrome in the proband, but the extremely mild phenotype in the other family members remains unexplained. In family B, the 1.1 Mb terminal deletion encompasses only the CHL1 gene, which is insufficient to cause 3p deletion symptoms; thus the clinical features observed in this family may have a different cause. The variable penetrance of 3p deletions creates challenges in genetic counseling, as the phenotype of the offspring cannot be predicted based on chromosomal and/or genome-wide array analytical findings.

Citing Articles

CHL1 deletion is associated with cognitive and language disabilities - Case report and review of literature.

Tsuboyama M, Iqbal M Mol Genet Genomic Med. 2021; 9(7):e1725.

PMID: 34056867 PMC: 8372067. DOI: 10.1002/mgg3.1725.


Familiar del3p syndrome: The uncertainty of the prognosis. A case report.

Martins M, Arantes R, Botelho P, Souto M, Moutinho O, Pinto Leite R Clin Case Rep. 2021; 9(4):2365-2368.

PMID: 33936696 PMC: 8077371. DOI: 10.1002/ccr3.4036.


Fetal Cystic Hygroma Associated with Terminal 2p25.1 Duplication and Terminal 3p25.3 Deletion: Cytogenetic, Fluorescent Hybridization and Microarray Familial Characterization of Two Different Chromosomal Structural Rearrangements.

Stipoljev F, Barbalic M, Logara M, Vicic A, Vulic M, Zekic Tomas S Balkan J Med Genet. 2021; 23(2):79-86.

PMID: 33816076 PMC: 8009571. DOI: 10.2478/bjmg-2020-0023.


Case Report: A Case Report and Literature Review of 3p Deletion Syndrome.

Fu J, Wang T, Fu Z, Li T, Zhang X, Zhao J Front Pediatr. 2021; 9:618059.

PMID: 33643973 PMC: 7902511. DOI: 10.3389/fped.2021.618059.


Cell Adhesion Molecules Involved in Neurodevelopmental Pathways Implicated in 3p-Deletion Syndrome and Autism Spectrum Disorder.

Gandawijaya J, Bamford R, Burbach J, Oguro-Ando A Front Cell Neurosci. 2021; 14:611379.

PMID: 33519384 PMC: 7838543. DOI: 10.3389/fncel.2020.611379.